Development of a microinstillation model of inhalation exposure to assess lung injury following exposure to toxic chemicals and nerve agents in guinea pigs

Toxicology Mechanisms and Methods

Volumn 16, Issue 6, 2006, Pages 295-306

  Nambiar, Madhusoodana ^a,b   Wright, Benjamin ^a   Rezk, Peter ^a   Smith, Kelvin ^a   Gordon, Richard ^a   Moran, Theodore ^c   Richards, Shannon ^c   Sciuto, Alfred ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Acetylcholinesterase; Bronchoalveolar Lavage; Chemical Warfare Agents; Guinea Pig; Microinstillation; Organophosphates; Pulmonary Injury; Respiratory System

Indexed keywords

ANAZOLENE SODIUM; CHEMICAL WARFARE AGENT; DYE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAROTRAUMA; CALCULATION; CATHETERIZATION; CONTROL SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE TIME EFFECT RELATION; EXPERIMENT; EXPOSURE; GUINEA PIG; HISTOPATHOLOGY; INHALATION; INTUBATION; LUNG INJURY; LUNG LOBE; LUNG PARENCHYMA; LUNG TOXICITY; MALE; MEASUREMENT; MICROINSTILLATION; NONHUMAN; PRESSURE; PRIORITY JOURNAL; PUMP; TECHNIQUE; TECHNOLOGY; TIDAL VOLUME; TISSUE DISTRIBUTION; TRACHEA; VALIDATION PROCESS;

ANIMALIA; CAVIA;

EID: 33745128709     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510600748760     Document Type: Article

References (48)

1. Allon, N., Raveh, L., Gilat, E., Cohen, E., Grunwald, J., and Ashani, Y. 1998. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci. 43:121-128.
2. Anthony, J. S., Haley, M., Manthei, J., Way, R., Burnett, D., Gaviola, B., Sommerville, D., Crosier, R., Mioduszewski, R., Thomson, S., Crouse, C., and Matson, K. 2004. Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: Potency comparison to sarin (GB). Inhal. Toxicol. 16:103-111.
3. Anzueto, A., de Lemos, R. A., Seidenfeld, J., Moore, G., Hamil, H., Johnson, D., and Jenkinson, S. G. 1990. Acute inhalation toxicity of soman and sarin in baboons. Fundam. Appl. Toxicol. 14:676-687.
4. Bajgar, J., Sevelova, L., Krejcova, G., Fusek, J., Vachek, J., Kassa, J., Herink, J., De Jong, L. P., and Benschop, H. P. 2004. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 16:497-507.
5. Benschop, H. P., Trap, H. C., Spruit, H. E., van der Wiel, H. J., Langenberg, J. P., and De Jong, L. P. 1998. Low level nose-only exposure to the nerve agent soman: Toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 153:179-185.
6. Bide, R. W., and Risk, D. J. 2004. Inhalation toxicity in mice exposed to sarin (GB) for 20-720 min. J. Appl. Toxicol. 24:459-467.
7. Bond, J. A., Dahl, A. R., Henderson, R. F., and Birnbaum, L. S. 1987. Species differences in the distribution of inhaled butadiene in tissues. Am. Ind. Hyg. Assoc. J. 48:867-872.
8. Broomfield, C. A., and Kirby, S. D. 2001. Progress on the road to new nerve agent treatments. J. Appl. Toxicol. 21(Suppl 1):S43-S46.
9. Buchanan, K. C., Burge, R. R., and Ruble, G. R. 1998. Evaluation of injectable anesthetics for major surgical procedures in guinea pigs. Contemp. Top. Lab Anim Sci. 37:58-63.
10. Caranto, G. R., Waibel, K. H., Asher, J. M., Larrison, R. W., Brecht, K. M., Schutz, M. B., Raveh, L., Ashani, Y., Wolfe, A. D., and Maxwell, D. M. 1994. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem. Pharmacol. 47:347-357.
11. Clark, A. R. 1996. MDIs: Physics of aerosol formation. J. Aerosol Med. 9(Suppl 1):S19-S26.
12. Clark, A. R., Gonda, I., and Newhouse, M. T. 1998. Towards meaningful laboratory tests for evaluation of pharmaceutical aerosols. J. Aerosol Med. 11(Suppl 1):S1-S7.
13. Dabisch, P. A., Burnett, D. C., Miller, D. B., Jakubowski, E. M., Muse, W. T., Forster, J. S., Scotto, J. A., Jarvis, J. R., Davis, E. A., Hulet, S. W., Reutter, S. A., Mioduszewski, R. J., and Thomson, S. A. 2005a. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures. J. Ocul. Pharmacol. Ther. 21:182-195.
14. Dabisch, P. A., Miller, D. B., Reutter, S. A., Mioduszewski, R. J., and Thomson, S. A. 2005b. Miotic tolerance to sarin vapor exposure: Role of the sympathetic and parasympathetic nervous systems. Toxicol. Sci. 85:1041-1047.
15. Dacre, J. C., and Goldman, M. 1996. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 48:289-326.
16. DeLorenzo, R. A. 2001. Exposed. Signs, symptoms & EMS management of nerve-agent poisoning. J Emerg. Med. Serv. JEMS. 26:48-57.
17. Ellman, G. L., Courtney, K. D., Andres, V., Jr., and Feather-Stone, R. M. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
18. Fok, T. F., Monkman, S., Dolovich, M., Gray, S., Coates, G., Paes, B., Rashid, F., Newhouse, M., and Kirpalani, H. 1996. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 21:301-309.
19. Hamilton, M. G., Hill, I., Conley, J., Sawyer, T. W., Caneva, D. C., and Lundy, P. M. 2004. Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: Effects of application site and decontamination. Mil. Med. 169:856-862.
20. Henderson, R. F., Barr, E. B., Blackwell, W. B., Clark, C. R., Conn, C. A., Kalra, R., March, T. H., Sopori, M. L., Tesfaigzi, Y., Menache, M. G., and Mash, D. C. 2002. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 184:67-76.
21. Holstege, C. P., Kirk, M., and Sidell, F. R. 1997. Chemical warfare. Nerve agent poisoning. Crit Care Clin. 13:923-942.
22. Jimmerson, V. R., Shih, T. M., Maxwell, D. M., Kaminskis, A., and Mailman, R. B. 1989a. The effect of 2-(o-cresyl)-4H-1:3:2-benzodioxaphosphorin- 2-oxide on tissue cholinesterase and carboxylesterase activities of the rat. Fundam. Appl. Toxicol. 13:568-575.
23. Jimmerson, V. R., Shih, T. M., Maxwell, D. M., and Mailman, R. B. 1989b. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat. Toxicol. Lett. 48:93-103.
24. Kadivar, H., and Adams, S. C. 1991. Treatment of chemical and biological warfare injuries: Insights derived from the 1984 Iraqi attack on Majnoon Island. Mil. Med. 156:171-177.
25. Karalliedde, L., Gauci, C. A., and Carter, M. 1991. Chemical weapons. BMJ 302:474.
26. Karalliedde, L., Wheeler, H., Maclehose, R., and Murray, V. 2000. Possible immediate and long-term health effects following exposure to chemical warfare agents. Public Health 114:238-248.
27. Kassa, J., Koupilova, M., Herink, J., and Vachek, J. 2001. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica. (Hradec. Kralove) 44:21-27.
28. Kassa, J., Krejcova, G., Skopec, F., Herink, J., Bajgar, J., Sevelova, L., Tichy, M., and Pecka, M. 2004a. The influence of sarin on various physiological functions in rats following single or repeated low-level inhalation exposure. Inhal. Toxicol. 16:517-530.
29. Kassa, J., Krocova, Z., Sevelova, L., Sheshko, V., Kasalova, I., and Neubauerova, V. 2004b. The alteration of immune reactions in inbred BALB/c mice following low-level sarin inhalation exposure. Inhal. Toxicol. 16:509-515.
30. Koping-Hoggard, M., Issa, M. M., Kohler, T., Tronde, A., Varum, K. M., and Artursson, P. 2005. A miniaturized nebulization catheter for improved gene delivery to the mouse lung. J. Gene Med. 7:1215-1222.
31. Krondahl, E., Tronde, A., Eirefelt, S., Forsmo-Bruce, H., Ekstrom, G., Bengtsson, U. H., and Lennernas, H. 2002. Regional differences in bioavailability of an opioid tetrapeptide in vivo in rats after administration to the respiratory tract. Peptides 23:479-488.
32. Langenberg, J. P., Spruit, H. E., van der Wiel, H. J., Trap, H. C., Helmich, R. B., Bergers, W. W., van Helden, H. P., and Benschop, H. P. 1998. Inhalation toxicokinetics of soman stereoisomers in the atropinized guinea pig with nose-only exposure to soman vapor. Toxicol. Appl. Pharmacol. 151:79-87.
33. Levy, A., Chapman, S., Cohen, G., Raveh, L., Rabinovitz, I., Manistersky, E., Kapon, Y., Allon, N., and Gilat, E. 2004. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: Comparative efficacy of three oximes. J. Appl. Toxicol. 24:501-504.
34. Maxwell, D. M., and Brecht, K. M. 1991. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 15:135-139.
35. Maxwell, D. M., Brecht, K. M., and O'Neill, B. L. 1987. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol. Lett. 39:35-42.
36. Mioduszewski, R., Manthei, J., Way, R., Burnett, D., Gaviola, B., Muse, W., Thomson, S., Sommerville, D., and Crosier, R. 2002. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats. Toxicol. Sci. 66:176-184.
37. Munro, N. 1994. Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: Implications for public protection. Environ. Health Perspect. 102:18-37.
38. Newth, C. J., and Clark, A. R. 1989. In vitro performance of the small particle aerosol generator (SPAG-2). Pediatr. Pulmonol. 7:183-188.
39. Pauluhn, I., and Mohr, U. 2000. Inhalation studies in laboratory animals-current concepts and alternatives. Toxicol. Pathol. 28:734-753.
40. Ritter, D., Knebel, J., and Aufderheide, M. 2004. Comparative assessment of toxicities of mainstream smoke from commercial cigarettes. Inhal. Toxicol. 16:691-700.
41. Sevelova, L., Vachek, J., and Bajgar, J. 2003b. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Medica. (Hradec. Kralove) 46:157-161.
42. Sevelova, L., Vachek, J., and Bajgar, J. 2003a. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Medica. (Hradec. Kralove) 46:157-161.
43. Spruit, H. E., Langenberg, J. P., Trap, H. C., van der Wiel, H. J., Helmich, R. B., van Helden, H. P., and Benschop, H. P. 2000. Intravenous and inhalation toxicokinetics of sarin stereoisomers in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 169:249-254.
44. Tronde, A., Baran, G., Eirefelt, S., Lennernas, H., and Bengtsson, U. H. 2002. Miniaturized nebulization catheters: A new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med. 15:283-296.
45. van Helden, H. P., Kuijpers, W. C., and Diemel, R. V. 2004a. Asthmalike symptoms following intratracheal exposure of Guinea pigs to sulfur mustard aerosol: Therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 16:537-548.
46. van Helden, H. P., Vanwersch, R. A., Kuijpers, W. C., Trap, H. C., Philippens, I. H., and Benschop, H. P. 2004b. Low levels of sarin affect the EEG in marmoset monkeys: A pilot study. J. Appl. Toxicol. 24:475-483.
47. von der, H. K., Kandler, M. A., Popp, K., Schoof, E., Chada, M., Rascher, W., and Dotsch, J. 2002a. Aerosolized adrenomedullin suppresses pulmonary transforming growth factor-betal and interleukin-1 beta gene expression in vivo. Eur. J. Pharmacol. 457:71-76.
48. von der, H. K., Schoof, E., Kandler, M. A., Dotsch, J., and Rascher, W. 2002b. Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr. Res. 51:177-182.